Israeli-Founded AI Biotech Immunai Collaborates with Boehringer Ingelheim

Israeli-founded AI biotech company Immunai has launched a drug-discovery collaboration with Boehringer Ingelheim, utilizing Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.

25 Jun, 16:01 — 25 Jun, 16:01

Post Share

Sources

Showing 1 of 1 sources

jerusalem-postMostly Factual65d ago

Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim

The collaboration will use Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.

Read full article →

Israeli-Founded AI Biotech Immunai Collaborates with Boehringer Ingelheim

Sources

Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim

Related Stories

Indian Prime Minister Modi Receives Uzbekistan’s Highest State Honour

Death Toll Climbs to 750 Following Devastating Floods in Nepal and Tibet

Norwegians Gather for Mourning Services Honoring Late King Harald V

Nepal Warns of Further Flooding Amid Devastating Flood Aftermath